CE: Hematologic Childhood Cancers: An Evidence-Based Review

Jessica Lynne Spruit1

  • 1Jessica Lynne Spruit is an assistant clinical professor and specialty coordinator of the Pediatric Acute Care Nurse Practitioner program at Wayne State University, and a pediatric NP in the Division of Hematology/Oncology at Children's Hospital of Michigan, both in Detroit. Contact author: jessica.spruit@wayne.edu. The author and planners have disclosed no potential conflicts of interest, financial or otherwise. A podcast with the author is available at www.ajnonline.com.

Insights

Pediatric hematologic cancers impact children and families. This article reviews diagnoses, treatments, and essential nursing care for childhood blood cancers.

Area of Science:

  • Pediatric Hematology Oncology
  • Childhood Cancer Research
  • Hematologic Malignancies

Background:

  • Hematologic cancers are a significant health concern for children and adolescents in the U.S.
  • Diagnosis and treatment of these cancers create profound challenges for affected families.
  • Understanding the nuances of pediatric blood cancers is crucial for effective care.

Purpose of the Study:

  • To provide an overview of therapies for pediatric hematologic cancers.
  • To describe the presentations and diagnoses of various childhood blood cancers.
  • To explain treatments specific to each type of hematologic malignancy in children.

Main Methods:

  • Literature review of current therapeutic approaches for pediatric hematologic cancers.
  • Compilation of diagnostic criteria and clinical presentations for common childhood blood cancers.
  • Synthesis of evidence-based nursing care strategies, focusing on education and support.

Main Results:

  • Overview of diverse treatment modalities including chemotherapy, radiation, and stem cell transplantation.
  • Detailed descriptions of leukemia, lymphoma, and other hematologic malignancies in pediatric populations.
  • Emphasis on the critical role of nursing in patient and family education and supportive care.

Conclusions:

  • Comprehensive understanding of pediatric hematologic cancers is vital for healthcare providers.
  • Tailored treatment strategies are essential for improving outcomes in childhood blood cancers.
  • Effective nursing interventions significantly enhance the quality of life for children and families facing these diagnoses.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
788
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.0K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
612